| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
58,549,396 | 49,288,095 | 34,474,814 | 24,903,166 | 13,292,982 |
| Cost of Revenue
|
-38,016,850 | -31,351,028 | -23,716,688 | -16,906,767 | -8,531,312 |
|
Gross Profit
|
20,532,546 | 17,937,067 | 10,758,126 | 7,996,399 | 4,761,670 |
| Selling, General and Administrative Expenses
|
-5,208,360 | -3,714,477 | -2,754,208 | -1,935,475 | -1,205,925 |
|
Research and Development Expenses
|
-612,618 | -612,618 | -493,845 | -338,823 | -301,385 |
| Depreciation, Amortization and Depletion
|
-1,850,342 | -1,557,383 | -1,190,037 | -604,580 | -391,936 |
| Other Income/Expense, Operating
|
-6,345,592 | -6,878,734 | -2,821,069 | -2,010,699 | -1,373,219 |
|
Operating Income/Expenses
|
-14,016,912 | -12,763,212 | -7,259,159 | -4,889,577 | -3,272,465 |
|
Total Operating Profit/Loss
|
6,515,634 | 5,173,855 | 3,498,967 | 3,106,822 | 1,489,205 |
| Total Net Finance Income/Expense
|
161,090 | 188,505 | 85,271 | 108,682 | 61,439 |
| Net Investment Income
|
-62,817 | -26,747 | -13,239 | 2,968 | 4,280 |
| Irregular Income/Expenses
|
-134,795 | -136,246 | 71,102 | -178,591 | -488,854 |
|
Other Income/Expense, Non-Operating
|
46,125 | 80,808 | 84,161 | 62,283 | 60,680 |
|
Non-Operating Income/Expenses, Total
|
9,603 | 106,320 | 227,295 | -4,658 | -362,455 |
|
Pretax Income
|
6,525,237 | 5,280,175 | 3,726,262 | 3,102,164 | 1,126,750 |
|
Provision for Income Tax
|
-2,155,611 | -1,679,793 | -770,553 | -258,127 | -638,504 |
|
Net Income from Continuing Operations
|
4,369,626 | 3,600,382 | 2,955,709 | 2,844,037 | 488,246 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,369,626 | 3,600,382 | 2,955,709 | 2,844,037 | 488,246 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
4,369,626 | 3,600,382 | 2,955,709 | 2,844,037 | 488,246 |
|
Net Income Available to Common Stockholders
|
4,369,626 | 3,600,382 | 2,955,709 | 2,844,037 | 488,246 |
|
Diluted Net Income Available to Common Stockholders
|
4,369,626 | 3,600,382 | 2,955,709 | 2,844,037 | 488,246 |
| Basic EPS
|
13.60 | 11.20 | 9.28 | 8.96 | 1.60 |
| Diluted EPS
|
13.60 | 11.20 | 9.28 | 8.96 | 1.52 |
|
Basic Weighted Average Shares Outstanding
|
320,186.72 | 320,642.33 | 318,246.10 | 316,513.71 | 309,134.80 |
|
Diluted Weighted Average Shares Outstanding
|
320,186.72 | 321,021.63 | 318,500.26 | 316,570.41 | 314,534.20 |
|
Reported Normalized Basic EPS
|
16.48 | 13.12 | 10.32 | 10.08 | 3.36 |
|
Reported Normalized Diluted EPS
|
16.48 | 13.04 | 10.32 | 10.08 | 3.36 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
6,364,147 | 5,091,670 | 3,640,991 | 2,993,482 | 1,065,311 |
12/31/2022 - 5/17/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade